+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside

BP4917
88700-35-0
98%
Phytopurify
(+)-Borneol is a bicyclic monoterpene used for analgesia and anaesthesia in traditional Chinese and Japanese medicine, it and its enantiomer (-)-borneol have a highly efficacious positive modulating action at GABA(A) receptors at human recombinant alpha1beta2gamma2L GABA(A) receptors. Borneol specifically inhibits the nicotinic acetylcholine receptor (nAChR)-mediated effects in a noncompetitive way, can depress P-glycoprotein function by a NF-κB signaling mediated mechanism in a blood brain barrier in vitro model. Borneol has neuroprotection through the inhibition of IκBα-NF-κB and translocation signaling pathway, it also has an anti-cerebral ischemia effects. It can suppresse inflammatory responses in LPS-induced acute lung injury through inhibition of the NF-κB and MAPKs signaling pathways.
Catalog No Package Original Price Price Inventory Quantity Operating
BP4917-5mg 5mg
BP4917-10mg 10mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

TNF MAPK8 NFKB1 IL6
NOS3 BCL2
TNF NFKB1 HTR1A IL6 GABRA1 GABRB2 GABRG2 CRHR1

Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside Related Products

Product drug property prediction parameters

  • 158.3000

  • -.0320

  • -.0320

  • 3.7190

  • .5664

  • .5154

  • Low

  • 40.0949

  • 5.5743

  • Yes

  • No

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • No

  • No

  • No